Senior Hires for US Pharma Researcher

In the US, healthcare specialist Roger Green and Associates (RG+A) has appointed Deni Deasy Boekell as Vice President - Client Strategist; and Michael J. Epstein as Associate Director - Research.

Deasy Boekell has more than twenty years' experience in the global pharmaceutical industry, focusing on bio-pharma and including brand management, strategy and positioning, the commercial / clinical interface, insight and strategic planning. She held various positions at Merck, AstraMerck Inc., Astra and AstraZeneca. Deni holds a M.S. Degree in Biology from Villanova University in Villanova, PA. Neal Dunn, Executive VP Client Services, says her appointment 'bolsters RG+A's plan to employ experienced pharma and biotech professionals to manage our market research engagements with our clients.'

Epstein joins with over seven years' pharma MR experience, most recently with PDI research division TVG, Inc., and before this as a Senior Research Associate with Harris Interactive. He holds an MS in Public Policy Analysis from the University of Rochester and will complete his Ph.D. early next year. 'Mike's background in study design and statistical analysis has given him a strong foundation to provide our clients valuable support in translating research results to commercial decision-making', comments Andrew Ginsberg, Executive VP, Research.

The firm, headquartered in New Hope, PA, was established in 1991 and provides customised qual and quant solutions covering a wide range of therapeutic areas, based on a combination of custom research and proprietary tools. The latter include patient-centered simulating research system Dynamic Practice Simulation® (DPS®); Impact Modeling; QTMTM or Qualitative-to-Modeling; and qual interviewing technique Aspirational Segmentation.

Web site: www.rogergreen.com .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.

• Roger Green and Associates, Inc.
• All news